These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1255883)

  • 1. Immune cytolysis of human renal carcinoma mediated by xenogeneic immune ribonucleic acid.
    Brower PA; Dekernion JB; Ramming KP
    J Urol; 1976 Mar; 115(3):243-5. PubMed ID: 1255883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced renal cell carcinoma: treatment with xenogeneic immune ribonucleic acid and appropriate surgical resection.
    Skinner DG; Dekernion JB; Brower PA; Ramming KP; Pilch YH
    J Urol; 1976 Mar; 115(3):246-50. PubMed ID: 943577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
    Richie JP; Wang BS; Steele GD; Wilson RE; Mannick JA
    J Urol; 1981 Jul; 126(1):24-8. PubMed ID: 6166758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" ribonucleic acid: implications for immunotherapy.
    Veltman LL; Kern DH; Pilch YH
    Am J Obstet Gynecol; 1974 Aug; 119(7):959-65. PubMed ID: 4135321
    [No Abstract]   [Full Text] [Related]  

  • 5. Mediation of cytotoxic immune responses against human tumor-associated antigens by xenogeneic immune RNA.
    Kern DH; Fritze D; Drogemuller CR; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):97-103. PubMed ID: 1003510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
    Veltman LL; Kern DH; Pilch YH
    Cell Immunol; 1974 Sep; 13(3):367-77. PubMed ID: 4476236
    [No Abstract]   [Full Text] [Related]  

  • 7. Mediation of immune responses to tumor antigens in vitro by immune RNA.
    Kern DH; Drogemuller CR; Pilch YH
    Ann N Y Acad Sci; 1976; 276():278-302. PubMed ID: 1071964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune RNA therapy for renal cell carcinoma: survival and immunologic monitoring.
    Ramming KP; deKernion JB
    Ann Surg; 1977 Oct; 186(4):459-67. PubMed ID: 907390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA: implications for immunotherapy.
    Pilch YH; Veltman LL; Kern DH
    Surgery; 1974 Jul; 76(1):23-34. PubMed ID: 4841349
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo effect and parallel in vitro lymphocyte-mediated tumor cytolysis after Phase I xenogeneic immune RNA treatment of patients with widespread melanoma or metastatic renal cell carcinoma.
    Steele G; Wang BS; Richie J; Wilson RE; Ervin T; Yankee R; Fallon M; Mannick JA
    Cancer Res; 1980 Jul; 40(7):2377-82. PubMed ID: 6155992
    [No Abstract]   [Full Text] [Related]  

  • 11. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for malignant lesions in man using immunogenic ribonucleic acid.
    deKernion JB; Ramming KP; Brower P; Skinner DG; Pilch YH
    Am J Surg; 1975 Nov; 130(5):575-8. PubMed ID: 1200271
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
    Dodd MC; Scheetz ME; Rossio JL
    Ann N Y Acad Sci; 1973 May; 207():454-67. PubMed ID: 4517721
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune cytolysis of human tumor cells mediated by xenogeneic "immune" RNA.
    Pilch YH; Veltman LL; Kern DH
    Arch Surg; 1974 Jul; 109(1):30-4. PubMed ID: 4599773
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro assessment of cell-mediated immunity in patients with renal cell carcinoma.
    Montie JE; Straffon RA; Deodhar SD; Barna B
    J Urol; 1976 Mar; 115(3):239-42. PubMed ID: 1255882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of xenogeneic I-RNA therapy in patients with metastatic renal cell carcinoma.
    Steele G; Wang BS; Richie JP; Ervin T; Yankee R; Mannick JA
    Cancer; 1981 Mar; 47(6):1286-8. PubMed ID: 6164471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of cellular immunity to renal cell carcinoma.
    Daly JJ; Prout GR; Ahl CA; Lin JC
    J Urol; 1974 Apr; 111(4):448-52. PubMed ID: 4819368
    [No Abstract]   [Full Text] [Related]  

  • 19. [The role of immune RNA in the immunotherapy of malignant brain tumor (author's transl)].
    Nakamura O; Takakura K
    No To Shinkei; 1982 Apr; 34(4):333-9. PubMed ID: 6178420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity to tumor antigens in patients with renal cell carcinoma.
    Cummings KB; Peter JB; Kaufman JJ
    J Urol; 1973 Jul; 110(1):31-5. PubMed ID: 4713354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.